Miconazole Nitrate

Manufacturer
Chain Drug Consortium, LLC
Effective date
2019-12-17
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 23:50:56

Label at a glance#

ProductMiconazole Nitrate
Active ingredientMICONAZOLE NITRATE
Label structure9 sections

Indications and uses

for the cure of most athlete's foot, jock itch and ringworm

Dosage and administration

clean the affected area and dry thoroughly apply a thin layer of product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily for athlete's foot and ringworm, use daily for 4 weeks; for jock i...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Miconazole nitrate 2%

​ ​Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • for the cure of most athlete's foot, jock itch and ringworm

Warnings

WARNINGS SECTION

For external use only.

​Do not use

OTC - DO NOT USE SECTION

on children 2 years of age unless directed by a doctor.

​When using this product

OTC - WHEN USING SECTION

avoid contact with the eyes

​Stop and ask a doctor if

OTC - STOP USE SECTION

irritation occurs or there is no improvement within 4 weeks for athlete's foot and ringworm, or 2 weeks for jock itch.

​Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. Do not use on children under 2 years of age unless directed by a doctor.

​Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the affected area and dry thoroughly
  • apply a thin layer of product over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product
  • for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
  • for athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks
  • if conditions persist longer, consult a doctor
  • this product is not effective on the scalp or nails

​Other information

OTHER SAFETY INFORMATION

  • store between 59º - 86º
  • Flightly shake bottle to loosen settled powder

​Inactive ingredients

INACTIVE INGREDIENT SECTION

aldioxa, chloroxylenol, fragrance, imidurea, powdered cellulose, talc

​ ​Questions?

OTC - QUESTIONS SECTION

call 1-866-964-0939

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Premier Value

MiconazorbAF

Miconazole Nitrate 2%
Anti-fungal Powder

  • Moisture absorbing
  • Cures and soothes most athlete's foot, jock itch & ringworm
  • Soothes chafing

NET WT 2.5 OZ (71g)

PV Miconazorb AF Powder.jpgPV Miconazorb AF Powder.jpg

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MICONAZOLE NITRATEACTIVE INGREDIENTVW4H1CYW1K2
MICONAZOLEACTIVE MOIETY7NNO0D7S5M2
ALDIOXAINACTIVE INGREDIENT8T66I31YNK2
CHLOROXYLENOLINACTIVE INGREDIENT0F32U78V2Q2
IMIDUREAINACTIVE INGREDIENTM629807ATL2
POWDERED CELLULOSEINACTIVE INGREDIENTSMD1X3XO9M2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68016-64868016-648-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 21 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MLIQUID / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, EXTENDED RELEASE / ORAL156 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, DELAYED RELEASE / ORAL16 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDISC / EXTRACORPOREALNAExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / ORAL1582 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MCAPSULE / ORAL2430 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDISC / TOPICALNAExact identifier — unii candidate
16 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLSHAMPOO / TOPICAL60 mgExact identifier — unii candidate
3 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / BUCCAL4.5 mgExact identifier — unii candidate
16 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLCREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
CHLOROXYLENOLCHLOROXYLENOL0F32U78V2QCREAM / TOPICAL0.15 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MPOWDER, FOR SUSPENSION / ORAL1600 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, FILM COATED / ORAL392 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / SUBLINGUAL4.5 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MSUSPENSION / ORAL1600 mgExact identifier — unii candidate
16 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLLOTION / TOPICAL228 mgExact identifier — unii candidate
3 equally ranked IID candidates
CHLOROXYLENOLCHLOROXYLENOL0F32U78V2QSOLUTION / AURICULAR (OTIC)0.1 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDROPS / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, COATED / ORAL40.2 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, CHEWABLE / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f31ae9d0-3f79-5e2b-e053-2a95a90abb1ebb434a2f-1aba-46d9-976c-80ca325eba322023-01-25WarningsExact identifier
spl set id: bb434a2f-1aba-46d9-976c-80ca325eba32

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.